1. Home
  2. HLF vs ARDX Comparison

HLF vs ARDX Comparison

Compare HLF & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Herbalife Ltd.

HLF

Herbalife Ltd.

HOLD

Current Price

$17.07

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$7.74

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLF
ARDX
Founded
1980
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Other Pharmaceuticals
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
HLF
ARDX
Price
$17.07
$7.74
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
10
Target Price
$16.00
$12.95
AVG Volume (30 Days)
1.6M
6.4M
Earning Date
02-18-2026
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
264.95
N/A
EPS
3.11
N/A
Revenue
$4,961,900,000.00
$398,234,000.00
Revenue This Year
$1.12
$22.58
Revenue Next Year
$2.97
$32.18
P/E Ratio
$5.59
N/A
Revenue Growth
N/A
58.12
52 Week Low
$5.04
$3.21
52 Week High
$17.67
$8.40

Technical Indicators

Market Signals
Indicator
HLF
ARDX
Relative Strength Index (RSI) 64.60 61.18
Support Level $16.40 $7.59
Resistance Level $17.60 $8.02
Average True Range (ATR) 0.68 0.43
MACD -0.05 -0.02
Stochastic Oscillator 61.84 60.78

Price Performance

Historical Comparison
HLF
ARDX

About HLF Herbalife Ltd.

Herbalife Ltd is an international nutrition company that provides health and wellness products to consumers in 95 markets, which consist of countries and territories, through their direct-selling business model. Companies' products are weight management, targeted nutrition, Energy, Sports and Fitness, Outer Nutrition and Literature, Promotional, and Other. Weight management generates the majority of revenue from products like Meal replacements, protein shakes, drink mixes, weight loss enhancers, and healthy snacks. Geographically, the main segments are North America, Latin America, EMEA, Asia Pacific regions, and China.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: